Silence Therapeutics SLN
NASDAQ SLN
$19.77 -0.02 (-0.10%)
At close: Nov 11, 2026 · 4:00 PM EST

Silence Therapeutics (SLN) Return on Sales [ROS] (2020 - 2026)

Updated

Silence Therapeutics (SLN) recorded Return on Sales [ROS] of -11106.83% in the quarter ended Jun 30, 2026, down 409.06 percentage points from -10697.77% a year earlier and down 7377.68 percentage points from the prior quarter.

Analysis

Silence Therapeutics (SLN) Return on Sales [ROS] (2020 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, Silence Therapeutics reported Return on Sales [ROS] of -16292.84%, down 16146.47 percentage points from the prior year.

  • Annual Return on Sales [ROS] has a five-year change of -15638.58 percentage points (years ended Dec 2020 to Dec 2025).
  • Across earlier years, Return on Sales [ROS] came in at -146.38% in the year ended Dec 31, 2024 (+48.19 pp), -194.56% in the year ended Dec 31, 2023 (+83.15 pp), -277.71% in the year ended Dec 31, 2022 (+91.31 pp) and -369.02% in the year ended Dec 31, 2021 (+285.24 pp).
  • Quarterly Return on Sales [ROS] has ranged from -36650.00% in the quarter ended Dec 31, 2025 to -17.20% in the quarter ended Dec 31, 2024 over the past five years.
  • On a year-over-year basis, Return on Sales [ROS] rose in 1 of the last six quarters, with an average year-over-year change of -10502.15 percentage points.
  • Per Business Quant, the preceding three quarters came in at -3729.15% (quarter ended Mar 31, 2026), -36650.00% (quarter ended Dec 31, 2025) and -16505.66% (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Silence Therapeutics 935.01 Mn 862.91 Mn - -11,106.83%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -11,106.83%
Mar 31, 2026 -3,729.15%
Dec 31, 2025 -36,650.00%
Sep 30, 2025 -16,505.66%
Jun 30, 2025 -10,697.77%
Mar 31, 2025 -20,006.34%
Dec 31, 2024 -17.20%
Sep 30, 2024 -2,002.47%
Jun 30, 2024 -2,923.50%
Mar 31, 2024 -35.55%
Dec 31, 2023 -633.59%
Sep 30, 2023 -453.86%
Jun 30, 2023 -125.85%
Mar 31, 2023 -106.81%
Dec 31, 2022 -230.03%
Sep 30, 2022 -404.06%
Jun 30, 2022 -386.74%
Mar 31, 2022 -173.40%
Dec 31, 2021 -329.91%
Sep 30, 2021 -389.23%
API Access

Silence Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=SLN&period=max&api_key=YOUR_API_KEY